activator in platelet membranes Evidence for a novel binding protein to urokinase-type plasminogen

http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml Information about subscriptions and ASH membership may be found online at:

[1]  M. Johnstone,et al.  The Selective Uptake of High Molecular Weight Urokinase-type Plasminogen Activator by Human Platelets , 1995 .

[2]  M. Johnstone,et al.  Platelet-Bound Prekallikrein Promotes Pro-Urokinase-Induced Clot Lysis: A Mechanism for Targeting the Factor XII Dependent Intrinsic Pathway of Fibrinolysis , 1994, Thrombosis and Haemostasis.

[3]  Møller Lb,et al.  Structure and function of the urokinase receptor. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[4]  V. Gurewich,et al.  Pro‐urokinase and prekallikrein are both associated with platelets , 1993, FEBS letters.

[5]  M. Llinás,et al.  Heparin binding to the urokinase kringle domain. , 1992, Biochemistry.

[6]  A. Schmaier,et al.  Insights on Monoclonal Antibodies to Kininogens' Heavy Chain Which Influence Kininogens' Binding to Platelets , 1992, Thrombosis and Haemostasis.

[7]  A. Schmaier,et al.  Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets. , 1992, The Journal of biological chemistry.

[8]  G. Dooijewaard,et al.  Physical Exercise Induces Enhancement of Urokinase-Type Plasminogen Activator (u-PA) Levels in Plasma , 1991, Thrombosis and Haemostasis.

[9]  D. Weiner,et al.  Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA. , 1990, Blood.

[10]  D. Vaughan,et al.  Urokinase binds to platelets through a specific saturable, low affinity mechanism , 1990 .

[11]  L. Harker,et al.  Demonstration of single chain urokinase-type plasminogen activator on human platelet membrane. , 1989, Blood.

[12]  F. Emmons,et al.  Spontaneous clot lysis in whole human plasma by endogenous tissue type and urokinase type plasminogen activators: Demonstration of a promoting effect by t-PA and by platelets on urokinase , 1988 .

[13]  E. Appella,et al.  The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases. , 1987, The Journal of biological chemistry.

[14]  V. Gurewich,et al.  A comparative study of the efficacy and specificity of tissue plasminogen activator and pro-urokinase: demonstration of synergism and of different thresholds of non-selectivity. , 1986, Thrombosis research.

[15]  K. Fujikawa,et al.  The activation of pro-urokinase by plasma kallikrein and its inactivation by thrombin. , 1986, The Journal of biological chemistry.

[16]  V. Gurewich,et al.  Effective and fibrin-specific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. , 1984, The Journal of clinical investigation.

[17]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Vaheri,et al.  Directed plasminogen activation at the surface of normal and malignant cells. , 1991, Advances in cancer research.

[19]  D. Collen,et al.  Activation of Plasminogen by Pro-urokinase , 1986 .

[20]  F. Castellino,et al.  Human plasminogen. , 1981, Methods in enzymology.

[21]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .